GigaGen Announces Appointment of Erica Stone, Ph.D., as Director, Immuno-Oncology

Dr. Stone will lead GigaGen's immuno-oncology research and discovery of first-in-class monoclonal antibody therapies SOUTH SAN FRANCISCO, Calif., Jan. 10, 2019 -- (Healthcare Sales & Marketing Network) -- GigaGen Inc., a biopharmaceutical company devel... Biopharmaceuticals, Oncology, Personnel GigaGen, immune dysregulation, immunotherapeutic
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news